NOVADOZ PHARMACEUTICALS LLC recalls Glycopyrrolate Oral Solution
- Published
- 4 Feb 2026
- Units affected
- N/A
- Agency
- FDA
- Country
- United States
The hazard
Failed Impurities/Degradation Specifications
Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72
- Brand / company
- NOVADOZ PHARMACEUTICALS LLC
- Codes / lots
- Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027
- Distribution
- US Nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 4 Feb 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.